Furthermore, the prevalence of mutations in TP53 and in other genes such RUNX1 in Fanconi anemia or dyskeratosis congenita appears to be much less than that of CSF3R in SCN (Chao et al., 2017; Lane, 2017; Kirschner et al., 2018). The gene discussed is TP53; the disease is Fanconi anemia.